PLUS THERAPEUTICS, Inc. Common Stock (PSTV) is a publicly traded Healthcare sector company. As of May 19, 2026, PSTV trades at $6.03 with a market cap of $36.03M and a P/E ratio of -19.12. PSTV moved +9.14% today. Year to date, PSTV is -57.91%; over the trailing twelve months it is -44.38%. Its 52-week range spans $2.90 to $57.75. Analyst consensus is strong buy with an average price target of $38.00. Rallies surfaces PSTV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PLUS THERAPEUTICS, Inc. Common Stock (PSTV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PSTV moved +9.14% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $6.03 |
| Market Cap | $36.03M |
| P/E Ratio | -19.12 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $57.75 |
| 52-Week Low | $2.90 |
| Volume | 38.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.21M |
| Net Income | $-22.39M |
| Gross Margin | 0.00% |
5 analysts cover PSTV: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.00.